Clinical Trial Update: Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab with the P-GemOx regimen (gemcitabine + oxaliplatin) for newly diagnosed advanced extranodal NK/T-cell lymphoma, nasal type;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Tyvyt (Sintilimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: NK/T Cell Lymphoma Nos | Phase 2 | Status: ACTIVE_NOT_RECRUITING